Comerica Bank reduced its stake in Keurig Dr Pepper, Inc (NASDAQ:KDP – Free Report) by 7.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 162,249 shares of the company’s stock after selling 12,409 shares during the quarter. Comerica Bank’s holdings in Keurig Dr Pepper were worth $5,552,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the business. Kovitz Investment Group Partners LLC raised its stake in shares of Keurig Dr Pepper by 6.5% in the fourth quarter. Kovitz Investment Group Partners LLC now owns 13,087 shares of the company’s stock valued at $420,000 after purchasing an additional 801 shares in the last quarter. Coldstream Capital Management Inc. grew its holdings in shares of Keurig Dr Pepper by 14.7% during the fourth quarter. Coldstream Capital Management Inc. now owns 10,288 shares of the company’s stock worth $330,000 after purchasing an additional 1,316 shares during the last quarter. Tudor Investment Corp ET AL grew its holdings in shares of Keurig Dr Pepper by 10.1% during the fourth quarter. Tudor Investment Corp ET AL now owns 17,362 shares of the company’s stock worth $558,000 after purchasing an additional 1,597 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Keurig Dr Pepper by 15.2% during the fourth quarter. The Manufacturers Life Insurance Company now owns 721,070 shares of the company’s stock worth $23,161,000 after purchasing an additional 95,409 shares during the last quarter. Finally, Utah Retirement Systems boosted its holdings in Keurig Dr Pepper by 6.0% in the fourth quarter. Utah Retirement Systems now owns 185,797 shares of the company’s stock valued at $5,968,000 after acquiring an additional 10,500 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Keurig Dr Pepper Price Performance
Shares of KDP stock opened at $29.29 on Friday. The company has a quick ratio of 0.40, a current ratio of 0.64 and a debt-to-equity ratio of 0.56. Keurig Dr Pepper, Inc has a twelve month low of $28.70 and a twelve month high of $38.28. The company has a market cap of $39.79 billion, a P/E ratio of 26.15, a P/E/G ratio of 1.63 and a beta of 0.45. The business has a fifty day simple moving average of $33.45 and a 200 day simple moving average of $33.60.
Insider Transactions at Keurig Dr Pepper
In other news, Director Robert James Gamgort sold 208,000 shares of the firm’s stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the transaction, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director De Ven Michael G. Van bought 15,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 4th. The shares were acquired at an average cost of $33.20 per share, with a total value of $498,000.00. Following the purchase, the director directly owned 15,000 shares of the company’s stock, valued at $498,000. This trade represents a ? increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold 679,601 shares of company stock worth $22,508,712 over the last ninety days. 0.40% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Several brokerages have commented on KDP. JPMorgan Chase & Co. dropped their target price on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an “overweight” rating for the company in a research report on Thursday, July 17th. Hsbc Global Res lowered Keurig Dr Pepper from a “strong-buy” rating to a “hold” rating in a research report on Tuesday. Jefferies Financial Group set a $41.00 target price on Keurig Dr Pepper in a research report on Monday. Deutsche Bank Aktiengesellschaft dropped their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, UBS Group decreased their price target on Keurig Dr Pepper from $40.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday. Eleven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $38.38.
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- Transportation Stocks Investing
- Snowflake’s Snowballing Business and Robust Stock Price Outlook
- How to find penny stocks to invest and trade
- Chevron Stock Outlook: Dividend Growth Meets Inflation
- Health Care Stocks Explained: Why You Might Want to Invest
- Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick?
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.